Association between dexmedetomidine use and neurological outcomes in aneurysmal subarachnoid hemorrhage patients: A retrospective observational study
Journal of Critical Care Mar 01, 2018
Okazaki T, et al. - Whether dexmedetomidine (DEX) use is associated with favorable neurological outcomes (FO) in subarachnoid hemorrhage (SAH) patients, was retrospectively investigated. Findings showed an association of low dosage DEX during the first 24 h after admission with FO in SAH patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
